Cordant Inc’s US Physical Therapy USPH Stock Holding History

Cordant Inc’s Portfolio USPH Stock Details USPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5	Closed	-$1K	–	354
2021 Q3	$1K	Buy	+5	New	+$570	﹤0.01%	330

Other funds holding USPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cordant Inc's USPH Position: Q4 2021 in Review

Cordant Inc sold out of US Physical Therapy (USPH) in Q4 2021, closing a stake of 5 shares — an estimated $1K sold.

Cordant Inc first reported a position in USPH in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 210 funds tracked by Wall St. Rank hold USPH as of Q4 2021.

Cordant Inc reported no remaining US Physical Therapy position as of Q4 2021 after selling out during the quarter.
Cordant Inc sold 5 US Physical Therapy shares in Q4 2021, an estimated $1K.
Cordant Inc first reported a position in US Physical Therapy in Q3 2021 and held it in 1 quarter.
Cordant Inc's US Physical Therapy position peaked at $1K in Q3 2021.
210 funds tracked by Wall St. Rank held US Physical Therapy as of Q4 2021.

Based on Cordant Inc's 13F filing for Q4 2021, filed 25 Jan 2022.